280 Followers on Owler

Akero

is a California-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of metabolic diseases... Read more
OverviewCompetitorsFundingNews & Insights

Akero

is a California-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of metabolic diseases... Read more
Akero President & CEO: Andrew Cheng

President & CEO

Andrew Cheng

CEO Approval Rating

81/100

2017

PublicNASDAQAKRO

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
<$1M
Employees
30
Funding
$1.4B

News

Funding
Jan 31, 2025
GlobeNewswire
Akero received $402.5M in Post-IPO Equity Funding
Conference Presentation
Nov 26, 2024
Benzinga
Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference

Akero Competitors

1Albireo
2Alnylam
3Altimmune
4Arrowhead
5Axcella
6Intercept
7Genentech
8Ocera
9Amgen
10Merck
Unlock 16 + competitors

Trending Companies